Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

843
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
843
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

269
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
269
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

225
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
225
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

377
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
377
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

369
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
369
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

316
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
316

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clustering of countries based on national essential medicines lists: cross-sectional study.

BMJ global health·2026
Same author

Discrepancies in Study of Vouchers for Healthy Foods and Diabetes-Reply.

JAMA internal medicine·2026
Same author

Rarely listed essential medicines in 158 national lists.

Journal of pharmaceutical policy and practice·2026
Same author

An essential medicines list in Ireland: A qualitative interview study of interest-holders.

Health policy (Amsterdam, Netherlands)·2026
Same author

Screening for potentially inappropriate prescribing in primary care: Canadian guideline.

Canadian family physician Medecin de famille canadien·2026
Same author

Canadian family physician Medecin de famille canadien·2026

Related Experiment Video

Updated: Feb 16, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.3K

Medication coverage for lawmakers may worsen access for everyone else.

Michael S Taglione1, Andrew Boozary2, Nav Persaud3

  • 1University of Toronto, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada.

Preventive Medicine
|January 1, 2018
PubMed
Summary

Canadian lawmakers have superior prescription drug coverage compared to the public. Implementing universal public drug coverage could improve medication access for all citizens, including politicians.

More Related Videos

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.2K
Accessing the Cytotoxicity and Cell Response to Biomaterials
09:46

Accessing the Cytotoxicity and Cell Response to Biomaterials

Published on: July 8, 2021

4.6K

Related Experiment Videos

Last Updated: Feb 16, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.3K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.2K
Accessing the Cytotoxicity and Cell Response to Biomaterials
09:46

Accessing the Cytotoxicity and Cell Response to Biomaterials

Published on: July 8, 2021

4.6K

Area of Science:

  • Health Policy
  • Pharmaceutical Access
  • Canadian Healthcare System

Background:

  • Millions of Canadians face challenges affording prescription medications.
  • Canada lacks universal first-dollar public drug coverage despite recommendations.
  • A fragmented system of 46 programs offers partial drug coverage to vulnerable groups.

Purpose of the Study:

  • To examine the disparity in prescription drug coverage between Canadian lawmakers and the general public.
  • To propose solutions for improving universal medication access in Canada.

Main Methods:

  • Comparative analysis of drug coverage plans for lawmakers versus public programs.
  • Review of existing literature on medication affordability and access in Canada.

Main Results:

  • Canadian lawmakers benefit from comprehensive personal drug coverage.
  • The public relies on a patchwork of limited public and private drug coverage options.
  • Disparities in drug access may influence policy decisions.

Conclusions:

  • Reducing the coverage gap between lawmakers and the public is essential for advancing universal medication access.
  • Improving the existing patchwork system or implementing a universal first-dollar drug plan are potential solutions.
  • A universal drug plan offers the most equitable approach to enhance medication access for all Canadians.